Zoetis reported $2.5B in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Align Technology ALGN:US USD 1.04B 167.02M
Bayer BAYN:GR EUR 4.36B 949M
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Charles River Laboratories CRL:US USD 193.7M 6.62M
Coherus Biosciences CHRS:US USD 286.8M 11.32M
Dentsply International XRAY:US USD 418M 56M
Eli Lilly And LLY:US USD 2.62B 5.5M
Endo International Ordinary Shares ENDP:US USD 1.05B 137.68M
Henry Schein HSIC:US USD 123M 15M
Horizon Pharma HZNP:US USD 2.13B 237.96M
Idexx Laboratories IDXX:US USD 99.18M 15.19M
Illumina ILMN:US USD 1000M 289M
IQVIA Holdings Inc IQV:US USD 1.27B 154M
Jazz Pharmaceuticals JAZZ:US USD 482.67M 191.74M
Laboratory Of America LH:US USD 409.9M 658.9M
Lannett LCI:US USD 77.92M 9.94M
Neogen NEOG:US USD 100M 7.1M
Pacira Pharmaceuticals PCRX:US USD 109.42M 12.64M
Patterson Companies PDCO:US USD 140.28M 9.28M
Perrigo Ordinary Shares PRGO:US USD 468.7M 16.6M
Phibro Animal Health PAHC:US USD 76.28M 2.03M
Quest Diagnostics DGX:US USD 700M 90M
Teva Pharmaceutical Industries TEVA:US USD 2.22B 167M
Zoetis ZTS:US USD 2.5B 145M